Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...11121314151617181920...
CompanyDrug NameStatusIndication Group
YM BioSciences TheraCIM accomplished Phase IIAntineoplastic & immunomodulating agents
YM BioSciences TheraCIM in Phase IIIAntineoplastic & immunomodulating agents
YM BioSciences TheraCIM accomplished Phase IIAntineoplastic & immunomodulating agents
Encysive Thelin Approved in EU and AustraliaCardiovascular system
Celgene Thalomid accomplished Phase IIAntineoplastic & immunomodulating agents
Celgene Thalomid Approved in USAAntineoplastic & immunomodulating agents
Celgene Thalomid accomplished Phase IIAntineoplastic & immunomodulating agents
Celgene Thalomid in Phase IIAntineoplastic & immunomodulating agents
Celgene Thalomid Approved in USA and EuropeAntineoplastic & immunomodulating agents
Biovail Teveten SB accomplished Phase IICardiovascular system
Wex Tetrodin accomplished Phase IINervous system
Vivus Testosterone MDTS accomplished Phase IIGenito urinary system & sex hormones
Auxilium Testim Approved in USA, EU and CanadaSystemic hormonal preparations
3M test   
Schering-Plough Tenovil in Phase IIAntineoplastic & immunomodulating agents
Schering-Plough Temodar Approved in USA, EU and CanadaAntineoplastic & immunomodulating agents
Telik Telintra in Phase IIAntineoplastic & immunomodulating agents
Telik Telcyta and Taxotere in Phase IIAntineoplastic & immunomodulating agents
Telik Telcyta and Paraplatin in Phase IIAntineoplastic & immunomodulating agents
Telik Telcyta and Doxil in Phase IIIAntineoplastic & immunomodulating agents
...11121314151617181920...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.